Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain

Journal of Endocrinological Investigation

Volumn 32, Issue 9, 2009, Pages 746-751

  Al Salman, R A ^a   Al Basri, H A ^a   Al Sayyad, A S ^a   Hearnshaw, H M ^b  

^a Ministry of Health   (Bahrain)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Albuminuria; Bahrain; Risk factors; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; BAHRAIN; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GROUPS BY AGE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 74949116368     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346530     Document Type: Article

References (41)

1. Al-Zurba F. Latest studies clarify state of health in Bahrain. Diabetes Voice 2001, 46: 28-31.
2. Al-Mahroos F, McKeigue PM. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 1998, 21: 936-42.
3. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993, 328: 1676-85.
4. McIntosh A, Hutchinson A, Marshall S, et al. Clinical Guidelines and Evidence Review for Type 2 Diabetes, Renal Disease: Prevention and Early Management. Sheffield: ScHARR, University of Sheffield, 2002.
5. Wu AY, Kong NC, de Leon FA, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005, 48: 17-26.
6. Gerstein HC, Mann JF, Yi Q, et al; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286: 421-6.
7. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28: 164-76.
8. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Int Med 1997, 157: 1413-8.
9. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996, 27: 2033-9.
10. st ed. Berlin, Germany: Springer-Verlag, 1988.
11. Ahmedani MY, Hydrie MZ, Iqbal A, Gul A, Mirza WB, Basit A. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan: a multi-center study. J Pak Med Assoc 2005, 55: 382-6.
12. Al-Futaisi A, Al-Zakwani I, Almahrezi A, et al. Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: a cross-sectional observational study in Oman. Diab Res Clin Prac 2006, 72: 212-5.
13. Buranakitjaroen P, Deerochanawong C, Bunnag P. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand. J Med Assoc Thailand 2005, 88: 1624-9.
14. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001, 77: 399-402.
15. Modebe O, Masoomi MA. Microalbuminuria and associated factors in Bahraini patients with type 2 diabetes mellitus. Ann Saudi Med 2000, 20: 157-60.
16. Salman R. Evaluation of diabetes service provision in a government health centre in Bahrain. Bahrain Med Bull 2005, 27: 3-12.
17. Al Khaja KA, Sequeira R, Damanhori AH. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain. J Eval Clin Pract 2005, 11: 121-31.
18. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006, 29 (Suppl 1): S4-42.
19. Lepore G, Maglio ML, Nosari I, Dodesini AR, Trevisan R. Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes. Diabetes Care 2002, 25: 2103-4.
20. Myers GL, Miller WG, Coresh J, et al; National Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006, 52: 5-18.
21. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva: World Health Organization, 1999.
22. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289: 2560-72.
23. Williams B, Poulter NR, Brown MJ, et al; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004, 18: 139-85.
24. st ed. London: Royal Society of Medicine Press, 2001.
25. nd ed, London: Blackwell Science Ltd, 2003.
26. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diab Res Clin Pract 2005, 67: 258-66.
27. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscl Thromb 1993, 13: 205-10.
28. Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW. Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 1989, 38: 1602-10.
29. Hamman RF, Franklin GA, Mayer EJ, et al. Microvascular complications of NIDDM in Hispanics and non-Hispanic whites. San Luis Valley Diabetes Study. Diabetes Care 1991, 14: 655-64.
30. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997, 314: 783-8.
31. Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan-incidence, risk factors, prognosis and causes of death. Diab Res Clin Pract 1989, 7: 299-306.
32. Song K-H, Yoon K-H, Kang M-I, et al. Progression to overt proteinuria in microalbuminuric Koreans with non-insulin-dependent diabetes mellitus. Diab Res Clin Pract 1998, 42: 117-21.
33. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003, 254: 45-66.
34. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002, 15: 244-50.
35. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care 1997, 20: 1435-41.
36. Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 1996, 11: 449-56.
37. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998, 158: 998-1004.
38. Martinez MA, Moreno A, Aguirre de Cárcer A, et al; MAPA-Madrid Working Group. Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study. J Hypertens 2001, 19: 319-26.
39. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000, 58: 1703-10.
40. Gerstein HC, Mann JF, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 2000, 23 (Suppl 2): B35-9.
41. Mattock MB, Barnes DJ, Viberti G, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 1998, 47: 1786-92.